DiaMedica Therapeutics to Present at CKD3 Kidney Summit Meeting

    NEXT STORY
    Innate Pharma to hold its Annual General Meeting of Shareholders on May 22, 2019 and the release of its 2018 Reference Document (in French)
    PREV STORY
    New data at AAN reinforce Novartis commitment to transforming the lives of people of all ages who live with neurological conditions
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Pfizer and BioNTech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints

    author_avatar
    NASDAQ Market News

    Roche enters into definitive merger agreement to acquire Spark Therapeutics

    author_avatar
    NASDAQ Market News

    Progenics Pharmaceuticals Announces Initiation of a Phase 1 Clinical Trial of its PSMA-Targeted Therapeutic Candidate 1095 For the Treatment of Metastatic Prostate Cancer

    NEW YORK, Feb. 14, 2017 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq:PGNX), an oncology ...

    author_avatar
    NASDAQ Market News